Biomedical prevention of HIV - HIV PrEP and HIV PEP

Download in PDF format
(213 KB, 2 pages)

Organization: Public Health Agency of Canada

Date published: 2024

Biomedical prevention of HIV - HIV PrEP and HIV PEP
 

HIV Pre-exposure prophylaxis (PrEP)

HIV Post-exposure prophylaxis (PEP)

What are PrEP and PEP?

HIV PrEP involves taking oral or injectable antiretroviral medications on an ongoing basis to prevent an HIV infection.

Intended for regular use as an ongoing HIV prevention method.

HIV PEP involves taking oral antiretroviral medications as soon as possible after a high-risk exposure to prevent an HIV infection.

Intended to prevent HIV transmission from a singular exposure.

When is it taken?

HIV PrEP is taken both before and after exposures that carry a high risk of HIV.

Oral HIV PrEP involves taking a pill once a day, on an ongoing basis.

Long-acting injectable PrEP is first given as two initiation injections one month apart, followed by an injection every two months thereafter.

HIV PEP should be started as soon as possible after a high-risk exposure to HIV, up to a maximum of 72 hours afterwards.

HIV PEP involves taking oral pills daily for 4 weeks (28 days).

HIV PEP can be taken on more than one occasion, if needed. However, individuals who have taken HIV PEP and are at ongoing risk of HIV exposure should consider taking HIV PrEP.

Who should be considered for PrEP and PEP?

HIV PrEP should be considered for individuals who do not have HIV and who participate in activities that have increased risk of exposure to HIV.Footnote *

Some sexual activities that have increased risk of HIV, including sex with:

  • no or inconsistent condom use; or
  • a partner(s) whose HIV status is unknown; or
  • a partner(s) who is living with HIV and who is not on treatmentFootnote **; or
  • the use of drugs or alcohol; or
  • the exchange for drugs or money.

Sharing drug use equipment is high risk for HIV.

A history of other sexually transmitted and blood-borne infections (STBBI) is a risk factor for HIV.

HIV PEP should be considered for individuals who do not have HIV and who have had a high-risk exposure to HIV.

A high-risk exposure could occur in a work context

  • e.g., exposure to blood or bodily fluids in a healthcare setting

Some sexual activities are high risk for HIV exposure

  • e.g., condomless sex with a partner who is living with HIV and who is not on treatmentFootnote **

HIV PEP may be recommended after a sexual assault.

*

The listed criteria can be used to identify people who may benefit from HIV PrEP, but is not exhaustive. It is reasonable to prescribe HIV PrEP to adults/adolescents who request it as some people may not feel comfortable disclosing their sexual or drug use behaviours to a healthcare provider.

Return to footnote * referrer

**

HIV is not passed on through sex when a person living with HIV is on treatment and the amount of HIV in their blood remains very low (the viral load is maintained at less than 200 copies/ml measured every 4 to 6 months).

Return to footnote ** referrer

Other considerations

For information on prescribing, please refer to the Canadian Guideline on HIV Pre-exposure Prophylaxis and Post-exposure Prophylaxis

Page details

Date modified: